1. Search Result
Search Result
Targets Recommended: NEDD8-activating Enzyme URAT1
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-132842

    EGFR Btk Cancer
    Sunvozertinib is a potent ErbBs (EGFR, Her2, especially mutant forms) and BTK inhibitor. Sunvozertinib shows IC50s of 20.4, 20.4, 1.1, 7.5, and 80.4 nM for EGFR exon 20 NPH insertion, EGFR exon 20 ASV insertion, EGFR L858R and T790M mutations, and Her2 Exon20 YVMA, and EGFR WT A431, respectively (patent WO2019149164A1, example 52).